Grand Pharmaceutical Group Limited (Grand Pharma) has announced a final ordinary dividend of HKD 0.169 per share for the financial year ended 31 December 2025, according to its filing with the Stock Exchange of Hong Kong.
Shareholders are scheduled to vote on the distribution at the annual general meeting on 5 June 2026. Subject to approval, the shares will trade ex-dividend on 12 June 2026.
The company’s Hong Kong share register will close for one day on 16 June 2026 to determine dividend entitlements. Investors must lodge share transfer documents with Computershare Hong Kong Investor Services by 16:30 on 15 June 2026.
Qualified shareholders on the 16 June 2026 record date are set to receive payment on 30 June 2026. The dividend will be paid in Hong Kong dollars at an exchange rate of HKD 1:HKD 1, and no withholding tax applies.
Grand Pharma’s board currently comprises four executive directors and four independent non-executive directors.
Comments